Global Nanobody Drug Supply, Demand and Key Producers, 2023-2029
The global Nanobody Drug market size is expected to reach $ 1637.9 million by 2029, rising at a market growth of 20.5% CAGR during the forecast period (2023-2029).
This report studies the global Nanobody Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nanobody Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nanobody Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nanobody Drug total production and demand, 2018-2029, (K Units)
Global Nanobody Drug total production value, 2018-2029, (USD Million)
Global Nanobody Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nanobody Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nanobody Drug domestic production, consumption, key domestic manufacturers and share
Global Nanobody Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nanobody Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nanobody Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Nanobody Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Sanofi Company(Ablynx), Merck KGaA, Jerry Corning, Shenzhen Pregene Biopharma Co, Novamab, PersonGen, Nanjing Legend Biotechnology Co., Ltd. and Taiwan Taisho Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nanobody Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nanobody Drug Market, By Region:
1. How big is the global Nanobody Drug market?
2. What is the demand of the global Nanobody Drug market?
3. What is the year over year growth of the global Nanobody Drug market?
4. What is the production and production value of the global Nanobody Drug market?
5. Who are the key producers in the global Nanobody Drug market?
This report studies the global Nanobody Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nanobody Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nanobody Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nanobody Drug total production and demand, 2018-2029, (K Units)
Global Nanobody Drug total production value, 2018-2029, (USD Million)
Global Nanobody Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nanobody Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nanobody Drug domestic production, consumption, key domestic manufacturers and share
Global Nanobody Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nanobody Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nanobody Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Nanobody Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Sanofi Company(Ablynx), Merck KGaA, Jerry Corning, Shenzhen Pregene Biopharma Co, Novamab, PersonGen, Nanjing Legend Biotechnology Co., Ltd. and Taiwan Taisho Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nanobody Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nanobody Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monovalent Nanobodies
- Multivalent Nanobodies
- Fusion Nanobodies
- Others
- Tumor Treatment
- Immune Disease Treatment
- Inflammatory Disease Treatment
- Others
- Boehringer Ingelheim
- Sanofi Company(Ablynx)
- Merck KGaA
- Jerry Corning
- Shenzhen Pregene Biopharma Co
- Novamab
- PersonGen
- Nanjing Legend Biotechnology Co., Ltd.
- Taiwan Taisho Pharmaceutical
- Yiteng Pharmaceutical
- Beijing Shuoxing Biotechnology
1. How big is the global Nanobody Drug market?
2. What is the demand of the global Nanobody Drug market?
3. What is the year over year growth of the global Nanobody Drug market?
4. What is the production and production value of the global Nanobody Drug market?
5. Who are the key producers in the global Nanobody Drug market?
1 SUPPLY SUMMARY
1.1 Nanobody Drug Introduction
1.2 World Nanobody Drug Supply & Forecast
1.2.1 World Nanobody Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Nanobody Drug Production (2018-2029)
1.2.3 World Nanobody Drug Pricing Trends (2018-2029)
1.3 World Nanobody Drug Production by Region (Based on Production Site)
1.3.1 World Nanobody Drug Production Value by Region (2018-2029)
1.3.2 World Nanobody Drug Production by Region (2018-2029)
1.3.3 World Nanobody Drug Average Price by Region (2018-2029)
1.3.4 North America Nanobody Drug Production (2018-2029)
1.3.5 Europe Nanobody Drug Production (2018-2029)
1.3.6 China Nanobody Drug Production (2018-2029)
1.3.7 Japan Nanobody Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nanobody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nanobody Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Nanobody Drug Demand (2018-2029)
2.2 World Nanobody Drug Consumption by Region
2.2.1 World Nanobody Drug Consumption by Region (2018-2023)
2.2.2 World Nanobody Drug Consumption Forecast by Region (2024-2029)
2.3 United States Nanobody Drug Consumption (2018-2029)
2.4 China Nanobody Drug Consumption (2018-2029)
2.5 Europe Nanobody Drug Consumption (2018-2029)
2.6 Japan Nanobody Drug Consumption (2018-2029)
2.7 South Korea Nanobody Drug Consumption (2018-2029)
2.8 ASEAN Nanobody Drug Consumption (2018-2029)
2.9 India Nanobody Drug Consumption (2018-2029)
3 WORLD NANOBODY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nanobody Drug Production Value by Manufacturer (2018-2023)
3.2 World Nanobody Drug Production by Manufacturer (2018-2023)
3.3 World Nanobody Drug Average Price by Manufacturer (2018-2023)
3.4 Nanobody Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nanobody Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nanobody Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Nanobody Drug in 2022
3.6 Nanobody Drug Market: Overall Company Footprint Analysis
3.6.1 Nanobody Drug Market: Region Footprint
3.6.2 Nanobody Drug Market: Company Product Type Footprint
3.6.3 Nanobody Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nanobody Drug Production Value Comparison
4.1.1 United States VS China: Nanobody Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nanobody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nanobody Drug Production Comparison
4.2.1 United States VS China: Nanobody Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nanobody Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nanobody Drug Consumption Comparison
4.3.1 United States VS China: Nanobody Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nanobody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nanobody Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nanobody Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nanobody Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nanobody Drug Production (2018-2023)
4.5 China Based Nanobody Drug Manufacturers and Market Share
4.5.1 China Based Nanobody Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nanobody Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Nanobody Drug Production (2018-2023)
4.6 Rest of World Based Nanobody Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nanobody Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nanobody Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nanobody Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nanobody Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monovalent Nanobodies
5.2.2 Multivalent Nanobodies
5.2.3 Fusion Nanobodies
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Nanobody Drug Production by Type (2018-2029)
5.3.2 World Nanobody Drug Production Value by Type (2018-2029)
5.3.3 World Nanobody Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nanobody Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tumor Treatment
6.2.2 Immune Disease Treatment
6.2.3 Inflammatory Disease Treatment
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nanobody Drug Production by Application (2018-2029)
6.3.2 World Nanobody Drug Production Value by Application (2018-2029)
6.3.3 World Nanobody Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Details
7.1.2 Boehringer Ingelheim Major Business
7.1.3 Boehringer Ingelheim Nanobody Drug Product and Services
7.1.4 Boehringer Ingelheim Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Boehringer Ingelheim Recent Developments/Updates
7.1.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.2 Sanofi Company(Ablynx)
7.2.1 Sanofi Company(Ablynx) Details
7.2.2 Sanofi Company(Ablynx) Major Business
7.2.3 Sanofi Company(Ablynx) Nanobody Drug Product and Services
7.2.4 Sanofi Company(Ablynx) Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Company(Ablynx) Recent Developments/Updates
7.2.6 Sanofi Company(Ablynx) Competitive Strengths & Weaknesses
7.3 Merck KGaA
7.3.1 Merck KGaA Details
7.3.2 Merck KGaA Major Business
7.3.3 Merck KGaA Nanobody Drug Product and Services
7.3.4 Merck KGaA Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck KGaA Recent Developments/Updates
7.3.6 Merck KGaA Competitive Strengths & Weaknesses
7.4 Jerry Corning
7.4.1 Jerry Corning Details
7.4.2 Jerry Corning Major Business
7.4.3 Jerry Corning Nanobody Drug Product and Services
7.4.4 Jerry Corning Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Jerry Corning Recent Developments/Updates
7.4.6 Jerry Corning Competitive Strengths & Weaknesses
7.5 Shenzhen Pregene Biopharma Co
7.5.1 Shenzhen Pregene Biopharma Co Details
7.5.2 Shenzhen Pregene Biopharma Co Major Business
7.5.3 Shenzhen Pregene Biopharma Co Nanobody Drug Product and Services
7.5.4 Shenzhen Pregene Biopharma Co Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Shenzhen Pregene Biopharma Co Recent Developments/Updates
7.5.6 Shenzhen Pregene Biopharma Co Competitive Strengths & Weaknesses
7.6 Novamab
7.6.1 Novamab Details
7.6.2 Novamab Major Business
7.6.3 Novamab Nanobody Drug Product and Services
7.6.4 Novamab Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Novamab Recent Developments/Updates
7.6.6 Novamab Competitive Strengths & Weaknesses
7.7 PersonGen
7.7.1 PersonGen Details
7.7.2 PersonGen Major Business
7.7.3 PersonGen Nanobody Drug Product and Services
7.7.4 PersonGen Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PersonGen Recent Developments/Updates
7.7.6 PersonGen Competitive Strengths & Weaknesses
7.8 Nanjing Legend Biotechnology Co., Ltd.
7.8.1 Nanjing Legend Biotechnology Co., Ltd. Details
7.8.2 Nanjing Legend Biotechnology Co., Ltd. Major Business
7.8.3 Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Product and Services
7.8.4 Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Nanjing Legend Biotechnology Co., Ltd. Recent Developments/Updates
7.8.6 Nanjing Legend Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.9 Taiwan Taisho Pharmaceutical
7.9.1 Taiwan Taisho Pharmaceutical Details
7.9.2 Taiwan Taisho Pharmaceutical Major Business
7.9.3 Taiwan Taisho Pharmaceutical Nanobody Drug Product and Services
7.9.4 Taiwan Taisho Pharmaceutical Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Taiwan Taisho Pharmaceutical Recent Developments/Updates
7.9.6 Taiwan Taisho Pharmaceutical Competitive Strengths & Weaknesses
7.10 Yiteng Pharmaceutical
7.10.1 Yiteng Pharmaceutical Details
7.10.2 Yiteng Pharmaceutical Major Business
7.10.3 Yiteng Pharmaceutical Nanobody Drug Product and Services
7.10.4 Yiteng Pharmaceutical Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Yiteng Pharmaceutical Recent Developments/Updates
7.10.6 Yiteng Pharmaceutical Competitive Strengths & Weaknesses
7.11 Beijing Shuoxing Biotechnology
7.11.1 Beijing Shuoxing Biotechnology Details
7.11.2 Beijing Shuoxing Biotechnology Major Business
7.11.3 Beijing Shuoxing Biotechnology Nanobody Drug Product and Services
7.11.4 Beijing Shuoxing Biotechnology Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Beijing Shuoxing Biotechnology Recent Developments/Updates
7.11.6 Beijing Shuoxing Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nanobody Drug Industry Chain
8.2 Nanobody Drug Upstream Analysis
8.2.1 Nanobody Drug Core Raw Materials
8.2.2 Main Manufacturers of Nanobody Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nanobody Drug Production Mode
8.6 Nanobody Drug Procurement Model
8.7 Nanobody Drug Industry Sales Model and Sales Channels
8.7.1 Nanobody Drug Sales Model
8.7.2 Nanobody Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nanobody Drug Introduction
1.2 World Nanobody Drug Supply & Forecast
1.2.1 World Nanobody Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Nanobody Drug Production (2018-2029)
1.2.3 World Nanobody Drug Pricing Trends (2018-2029)
1.3 World Nanobody Drug Production by Region (Based on Production Site)
1.3.1 World Nanobody Drug Production Value by Region (2018-2029)
1.3.2 World Nanobody Drug Production by Region (2018-2029)
1.3.3 World Nanobody Drug Average Price by Region (2018-2029)
1.3.4 North America Nanobody Drug Production (2018-2029)
1.3.5 Europe Nanobody Drug Production (2018-2029)
1.3.6 China Nanobody Drug Production (2018-2029)
1.3.7 Japan Nanobody Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nanobody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nanobody Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Nanobody Drug Demand (2018-2029)
2.2 World Nanobody Drug Consumption by Region
2.2.1 World Nanobody Drug Consumption by Region (2018-2023)
2.2.2 World Nanobody Drug Consumption Forecast by Region (2024-2029)
2.3 United States Nanobody Drug Consumption (2018-2029)
2.4 China Nanobody Drug Consumption (2018-2029)
2.5 Europe Nanobody Drug Consumption (2018-2029)
2.6 Japan Nanobody Drug Consumption (2018-2029)
2.7 South Korea Nanobody Drug Consumption (2018-2029)
2.8 ASEAN Nanobody Drug Consumption (2018-2029)
2.9 India Nanobody Drug Consumption (2018-2029)
3 WORLD NANOBODY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nanobody Drug Production Value by Manufacturer (2018-2023)
3.2 World Nanobody Drug Production by Manufacturer (2018-2023)
3.3 World Nanobody Drug Average Price by Manufacturer (2018-2023)
3.4 Nanobody Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nanobody Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nanobody Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Nanobody Drug in 2022
3.6 Nanobody Drug Market: Overall Company Footprint Analysis
3.6.1 Nanobody Drug Market: Region Footprint
3.6.2 Nanobody Drug Market: Company Product Type Footprint
3.6.3 Nanobody Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nanobody Drug Production Value Comparison
4.1.1 United States VS China: Nanobody Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nanobody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nanobody Drug Production Comparison
4.2.1 United States VS China: Nanobody Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nanobody Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nanobody Drug Consumption Comparison
4.3.1 United States VS China: Nanobody Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nanobody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nanobody Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nanobody Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nanobody Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nanobody Drug Production (2018-2023)
4.5 China Based Nanobody Drug Manufacturers and Market Share
4.5.1 China Based Nanobody Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nanobody Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Nanobody Drug Production (2018-2023)
4.6 Rest of World Based Nanobody Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nanobody Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nanobody Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nanobody Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nanobody Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monovalent Nanobodies
5.2.2 Multivalent Nanobodies
5.2.3 Fusion Nanobodies
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Nanobody Drug Production by Type (2018-2029)
5.3.2 World Nanobody Drug Production Value by Type (2018-2029)
5.3.3 World Nanobody Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nanobody Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tumor Treatment
6.2.2 Immune Disease Treatment
6.2.3 Inflammatory Disease Treatment
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nanobody Drug Production by Application (2018-2029)
6.3.2 World Nanobody Drug Production Value by Application (2018-2029)
6.3.3 World Nanobody Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Details
7.1.2 Boehringer Ingelheim Major Business
7.1.3 Boehringer Ingelheim Nanobody Drug Product and Services
7.1.4 Boehringer Ingelheim Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Boehringer Ingelheim Recent Developments/Updates
7.1.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.2 Sanofi Company(Ablynx)
7.2.1 Sanofi Company(Ablynx) Details
7.2.2 Sanofi Company(Ablynx) Major Business
7.2.3 Sanofi Company(Ablynx) Nanobody Drug Product and Services
7.2.4 Sanofi Company(Ablynx) Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Company(Ablynx) Recent Developments/Updates
7.2.6 Sanofi Company(Ablynx) Competitive Strengths & Weaknesses
7.3 Merck KGaA
7.3.1 Merck KGaA Details
7.3.2 Merck KGaA Major Business
7.3.3 Merck KGaA Nanobody Drug Product and Services
7.3.4 Merck KGaA Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Merck KGaA Recent Developments/Updates
7.3.6 Merck KGaA Competitive Strengths & Weaknesses
7.4 Jerry Corning
7.4.1 Jerry Corning Details
7.4.2 Jerry Corning Major Business
7.4.3 Jerry Corning Nanobody Drug Product and Services
7.4.4 Jerry Corning Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Jerry Corning Recent Developments/Updates
7.4.6 Jerry Corning Competitive Strengths & Weaknesses
7.5 Shenzhen Pregene Biopharma Co
7.5.1 Shenzhen Pregene Biopharma Co Details
7.5.2 Shenzhen Pregene Biopharma Co Major Business
7.5.3 Shenzhen Pregene Biopharma Co Nanobody Drug Product and Services
7.5.4 Shenzhen Pregene Biopharma Co Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Shenzhen Pregene Biopharma Co Recent Developments/Updates
7.5.6 Shenzhen Pregene Biopharma Co Competitive Strengths & Weaknesses
7.6 Novamab
7.6.1 Novamab Details
7.6.2 Novamab Major Business
7.6.3 Novamab Nanobody Drug Product and Services
7.6.4 Novamab Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Novamab Recent Developments/Updates
7.6.6 Novamab Competitive Strengths & Weaknesses
7.7 PersonGen
7.7.1 PersonGen Details
7.7.2 PersonGen Major Business
7.7.3 PersonGen Nanobody Drug Product and Services
7.7.4 PersonGen Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PersonGen Recent Developments/Updates
7.7.6 PersonGen Competitive Strengths & Weaknesses
7.8 Nanjing Legend Biotechnology Co., Ltd.
7.8.1 Nanjing Legend Biotechnology Co., Ltd. Details
7.8.2 Nanjing Legend Biotechnology Co., Ltd. Major Business
7.8.3 Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Product and Services
7.8.4 Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Nanjing Legend Biotechnology Co., Ltd. Recent Developments/Updates
7.8.6 Nanjing Legend Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.9 Taiwan Taisho Pharmaceutical
7.9.1 Taiwan Taisho Pharmaceutical Details
7.9.2 Taiwan Taisho Pharmaceutical Major Business
7.9.3 Taiwan Taisho Pharmaceutical Nanobody Drug Product and Services
7.9.4 Taiwan Taisho Pharmaceutical Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Taiwan Taisho Pharmaceutical Recent Developments/Updates
7.9.6 Taiwan Taisho Pharmaceutical Competitive Strengths & Weaknesses
7.10 Yiteng Pharmaceutical
7.10.1 Yiteng Pharmaceutical Details
7.10.2 Yiteng Pharmaceutical Major Business
7.10.3 Yiteng Pharmaceutical Nanobody Drug Product and Services
7.10.4 Yiteng Pharmaceutical Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Yiteng Pharmaceutical Recent Developments/Updates
7.10.6 Yiteng Pharmaceutical Competitive Strengths & Weaknesses
7.11 Beijing Shuoxing Biotechnology
7.11.1 Beijing Shuoxing Biotechnology Details
7.11.2 Beijing Shuoxing Biotechnology Major Business
7.11.3 Beijing Shuoxing Biotechnology Nanobody Drug Product and Services
7.11.4 Beijing Shuoxing Biotechnology Nanobody Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Beijing Shuoxing Biotechnology Recent Developments/Updates
7.11.6 Beijing Shuoxing Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nanobody Drug Industry Chain
8.2 Nanobody Drug Upstream Analysis
8.2.1 Nanobody Drug Core Raw Materials
8.2.2 Main Manufacturers of Nanobody Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nanobody Drug Production Mode
8.6 Nanobody Drug Procurement Model
8.7 Nanobody Drug Industry Sales Model and Sales Channels
8.7.1 Nanobody Drug Sales Model
8.7.2 Nanobody Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nanobody Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nanobody Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nanobody Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nanobody Drug Production Value Market Share by Region (2018-2023)
Table 5. World Nanobody Drug Production Value Market Share by Region (2024-2029)
Table 6. World Nanobody Drug Production by Region (2018-2023) & (K Units)
Table 7. World Nanobody Drug Production by Region (2024-2029) & (K Units)
Table 8. World Nanobody Drug Production Market Share by Region (2018-2023)
Table 9. World Nanobody Drug Production Market Share by Region (2024-2029)
Table 10. World Nanobody Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nanobody Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nanobody Drug Major Market Trends
Table 13. World Nanobody Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nanobody Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Nanobody Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nanobody Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nanobody Drug Producers in 2022
Table 18. World Nanobody Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nanobody Drug Producers in 2022
Table 20. World Nanobody Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nanobody Drug Company Evaluation Quadrant
Table 22. World Nanobody Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nanobody Drug Production Site of Key Manufacturer
Table 24. Nanobody Drug Market: Company Product Type Footprint
Table 25. Nanobody Drug Market: Company Product Application Footprint
Table 26. Nanobody Drug Competitive Factors
Table 27. Nanobody Drug New Entrant and Capacity Expansion Plans
Table 28. Nanobody Drug Mergers & Acquisitions Activity
Table 29. United States VS China Nanobody Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nanobody Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nanobody Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nanobody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nanobody Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nanobody Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nanobody Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nanobody Drug Production Market Share (2018-2023)
Table 37. China Based Nanobody Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nanobody Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nanobody Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nanobody Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nanobody Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Nanobody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nanobody Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nanobody Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nanobody Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nanobody Drug Production Market Share (2018-2023)
Table 47. World Nanobody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nanobody Drug Production by Type (2018-2023) & (K Units)
Table 49. World Nanobody Drug Production by Type (2024-2029) & (K Units)
Table 50. World Nanobody Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nanobody Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nanobody Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nanobody Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nanobody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nanobody Drug Production by Application (2018-2023) & (K Units)
Table 56. World Nanobody Drug Production by Application (2024-2029) & (K Units)
Table 57. World Nanobody Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nanobody Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nanobody Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nanobody Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 62. Boehringer Ingelheim Major Business
Table 63. Boehringer Ingelheim Nanobody Drug Product and Services
Table 64. Boehringer Ingelheim Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Boehringer Ingelheim Recent Developments/Updates
Table 66. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 67. Sanofi Company(Ablynx) Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Company(Ablynx) Major Business
Table 69. Sanofi Company(Ablynx) Nanobody Drug Product and Services
Table 70. Sanofi Company(Ablynx) Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Company(Ablynx) Recent Developments/Updates
Table 72. Sanofi Company(Ablynx) Competitive Strengths & Weaknesses
Table 73. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 74. Merck KGaA Major Business
Table 75. Merck KGaA Nanobody Drug Product and Services
Table 76. Merck KGaA Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck KGaA Recent Developments/Updates
Table 78. Merck KGaA Competitive Strengths & Weaknesses
Table 79. Jerry Corning Basic Information, Manufacturing Base and Competitors
Table 80. Jerry Corning Major Business
Table 81. Jerry Corning Nanobody Drug Product and Services
Table 82. Jerry Corning Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Jerry Corning Recent Developments/Updates
Table 84. Jerry Corning Competitive Strengths & Weaknesses
Table 85. Shenzhen Pregene Biopharma Co Basic Information, Manufacturing Base and Competitors
Table 86. Shenzhen Pregene Biopharma Co Major Business
Table 87. Shenzhen Pregene Biopharma Co Nanobody Drug Product and Services
Table 88. Shenzhen Pregene Biopharma Co Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Shenzhen Pregene Biopharma Co Recent Developments/Updates
Table 90. Shenzhen Pregene Biopharma Co Competitive Strengths & Weaknesses
Table 91. Novamab Basic Information, Manufacturing Base and Competitors
Table 92. Novamab Major Business
Table 93. Novamab Nanobody Drug Product and Services
Table 94. Novamab Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Novamab Recent Developments/Updates
Table 96. Novamab Competitive Strengths & Weaknesses
Table 97. PersonGen Basic Information, Manufacturing Base and Competitors
Table 98. PersonGen Major Business
Table 99. PersonGen Nanobody Drug Product and Services
Table 100. PersonGen Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PersonGen Recent Developments/Updates
Table 102. PersonGen Competitive Strengths & Weaknesses
Table 103. Nanjing Legend Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Nanjing Legend Biotechnology Co., Ltd. Major Business
Table 105. Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Product and Services
Table 106. Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Nanjing Legend Biotechnology Co., Ltd. Recent Developments/Updates
Table 108. Nanjing Legend Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 109. Taiwan Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Taiwan Taisho Pharmaceutical Major Business
Table 111. Taiwan Taisho Pharmaceutical Nanobody Drug Product and Services
Table 112. Taiwan Taisho Pharmaceutical Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Taiwan Taisho Pharmaceutical Recent Developments/Updates
Table 114. Taiwan Taisho Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Yiteng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Yiteng Pharmaceutical Major Business
Table 117. Yiteng Pharmaceutical Nanobody Drug Product and Services
Table 118. Yiteng Pharmaceutical Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Yiteng Pharmaceutical Recent Developments/Updates
Table 120. Beijing Shuoxing Biotechnology Basic Information, Manufacturing Base and Competitors
Table 121. Beijing Shuoxing Biotechnology Major Business
Table 122. Beijing Shuoxing Biotechnology Nanobody Drug Product and Services
Table 123. Beijing Shuoxing Biotechnology Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Nanobody Drug Upstream (Raw Materials)
Table 125. Nanobody Drug Typical Customers
Table 126. Nanobody Drug Typical Distributors
LIST OF FIGURE
Figure 1. Nanobody Drug Picture
Figure 2. World Nanobody Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nanobody Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nanobody Drug Production (2018-2029) & (K Units)
Figure 5. World Nanobody Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nanobody Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Nanobody Drug Production Market Share by Region (2018-2029)
Figure 8. North America Nanobody Drug Production (2018-2029) & (K Units)
Figure 9. Europe Nanobody Drug Production (2018-2029) & (K Units)
Figure 10. China Nanobody Drug Production (2018-2029) & (K Units)
Figure 11. Japan Nanobody Drug Production (2018-2029) & (K Units)
Figure 12. Nanobody Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 15. World Nanobody Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 17. China Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 22. India Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nanobody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nanobody Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nanobody Drug Markets in 2022
Figure 26. United States VS China: Nanobody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nanobody Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nanobody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nanobody Drug Production Market Share 2022
Figure 30. China Based Manufacturers Nanobody Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nanobody Drug Production Market Share 2022
Figure 32. World Nanobody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nanobody Drug Production Value Market Share by Type in 2022
Figure 34. Monovalent Nanobodies
Figure 35. Multivalent Nanobodies
Figure 36. Fusion Nanobodies
Figure 37. Others
Figure 38. World Nanobody Drug Production Market Share by Type (2018-2029)
Figure 39. World Nanobody Drug Production Value Market Share by Type (2018-2029)
Figure 40. World Nanobody Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Nanobody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Nanobody Drug Production Value Market Share by Application in 2022
Figure 43. Tumor Treatment
Figure 44. Immune Disease Treatment
Figure 45. Inflammatory Disease Treatment
Figure 46. Others
Figure 47. World Nanobody Drug Production Market Share by Application (2018-2029)
Figure 48. World Nanobody Drug Production Value Market Share by Application (2018-2029)
Figure 49. World Nanobody Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Nanobody Drug Industry Chain
Figure 51. Nanobody Drug Procurement Model
Figure 52. Nanobody Drug Sales Model
Figure 53. Nanobody Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World Nanobody Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nanobody Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nanobody Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nanobody Drug Production Value Market Share by Region (2018-2023)
Table 5. World Nanobody Drug Production Value Market Share by Region (2024-2029)
Table 6. World Nanobody Drug Production by Region (2018-2023) & (K Units)
Table 7. World Nanobody Drug Production by Region (2024-2029) & (K Units)
Table 8. World Nanobody Drug Production Market Share by Region (2018-2023)
Table 9. World Nanobody Drug Production Market Share by Region (2024-2029)
Table 10. World Nanobody Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nanobody Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nanobody Drug Major Market Trends
Table 13. World Nanobody Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nanobody Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Nanobody Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nanobody Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nanobody Drug Producers in 2022
Table 18. World Nanobody Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nanobody Drug Producers in 2022
Table 20. World Nanobody Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nanobody Drug Company Evaluation Quadrant
Table 22. World Nanobody Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nanobody Drug Production Site of Key Manufacturer
Table 24. Nanobody Drug Market: Company Product Type Footprint
Table 25. Nanobody Drug Market: Company Product Application Footprint
Table 26. Nanobody Drug Competitive Factors
Table 27. Nanobody Drug New Entrant and Capacity Expansion Plans
Table 28. Nanobody Drug Mergers & Acquisitions Activity
Table 29. United States VS China Nanobody Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nanobody Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nanobody Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nanobody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nanobody Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nanobody Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nanobody Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nanobody Drug Production Market Share (2018-2023)
Table 37. China Based Nanobody Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nanobody Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nanobody Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nanobody Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nanobody Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Nanobody Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nanobody Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nanobody Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nanobody Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nanobody Drug Production Market Share (2018-2023)
Table 47. World Nanobody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nanobody Drug Production by Type (2018-2023) & (K Units)
Table 49. World Nanobody Drug Production by Type (2024-2029) & (K Units)
Table 50. World Nanobody Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nanobody Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nanobody Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nanobody Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nanobody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nanobody Drug Production by Application (2018-2023) & (K Units)
Table 56. World Nanobody Drug Production by Application (2024-2029) & (K Units)
Table 57. World Nanobody Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nanobody Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nanobody Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nanobody Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 62. Boehringer Ingelheim Major Business
Table 63. Boehringer Ingelheim Nanobody Drug Product and Services
Table 64. Boehringer Ingelheim Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Boehringer Ingelheim Recent Developments/Updates
Table 66. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 67. Sanofi Company(Ablynx) Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Company(Ablynx) Major Business
Table 69. Sanofi Company(Ablynx) Nanobody Drug Product and Services
Table 70. Sanofi Company(Ablynx) Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Company(Ablynx) Recent Developments/Updates
Table 72. Sanofi Company(Ablynx) Competitive Strengths & Weaknesses
Table 73. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 74. Merck KGaA Major Business
Table 75. Merck KGaA Nanobody Drug Product and Services
Table 76. Merck KGaA Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Merck KGaA Recent Developments/Updates
Table 78. Merck KGaA Competitive Strengths & Weaknesses
Table 79. Jerry Corning Basic Information, Manufacturing Base and Competitors
Table 80. Jerry Corning Major Business
Table 81. Jerry Corning Nanobody Drug Product and Services
Table 82. Jerry Corning Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Jerry Corning Recent Developments/Updates
Table 84. Jerry Corning Competitive Strengths & Weaknesses
Table 85. Shenzhen Pregene Biopharma Co Basic Information, Manufacturing Base and Competitors
Table 86. Shenzhen Pregene Biopharma Co Major Business
Table 87. Shenzhen Pregene Biopharma Co Nanobody Drug Product and Services
Table 88. Shenzhen Pregene Biopharma Co Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Shenzhen Pregene Biopharma Co Recent Developments/Updates
Table 90. Shenzhen Pregene Biopharma Co Competitive Strengths & Weaknesses
Table 91. Novamab Basic Information, Manufacturing Base and Competitors
Table 92. Novamab Major Business
Table 93. Novamab Nanobody Drug Product and Services
Table 94. Novamab Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Novamab Recent Developments/Updates
Table 96. Novamab Competitive Strengths & Weaknesses
Table 97. PersonGen Basic Information, Manufacturing Base and Competitors
Table 98. PersonGen Major Business
Table 99. PersonGen Nanobody Drug Product and Services
Table 100. PersonGen Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PersonGen Recent Developments/Updates
Table 102. PersonGen Competitive Strengths & Weaknesses
Table 103. Nanjing Legend Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Nanjing Legend Biotechnology Co., Ltd. Major Business
Table 105. Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Product and Services
Table 106. Nanjing Legend Biotechnology Co., Ltd. Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Nanjing Legend Biotechnology Co., Ltd. Recent Developments/Updates
Table 108. Nanjing Legend Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 109. Taiwan Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Taiwan Taisho Pharmaceutical Major Business
Table 111. Taiwan Taisho Pharmaceutical Nanobody Drug Product and Services
Table 112. Taiwan Taisho Pharmaceutical Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Taiwan Taisho Pharmaceutical Recent Developments/Updates
Table 114. Taiwan Taisho Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Yiteng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Yiteng Pharmaceutical Major Business
Table 117. Yiteng Pharmaceutical Nanobody Drug Product and Services
Table 118. Yiteng Pharmaceutical Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Yiteng Pharmaceutical Recent Developments/Updates
Table 120. Beijing Shuoxing Biotechnology Basic Information, Manufacturing Base and Competitors
Table 121. Beijing Shuoxing Biotechnology Major Business
Table 122. Beijing Shuoxing Biotechnology Nanobody Drug Product and Services
Table 123. Beijing Shuoxing Biotechnology Nanobody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Nanobody Drug Upstream (Raw Materials)
Table 125. Nanobody Drug Typical Customers
Table 126. Nanobody Drug Typical Distributors
LIST OF FIGURE
Figure 1. Nanobody Drug Picture
Figure 2. World Nanobody Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nanobody Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nanobody Drug Production (2018-2029) & (K Units)
Figure 5. World Nanobody Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nanobody Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Nanobody Drug Production Market Share by Region (2018-2029)
Figure 8. North America Nanobody Drug Production (2018-2029) & (K Units)
Figure 9. Europe Nanobody Drug Production (2018-2029) & (K Units)
Figure 10. China Nanobody Drug Production (2018-2029) & (K Units)
Figure 11. Japan Nanobody Drug Production (2018-2029) & (K Units)
Figure 12. Nanobody Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 15. World Nanobody Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 17. China Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 22. India Nanobody Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nanobody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nanobody Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nanobody Drug Markets in 2022
Figure 26. United States VS China: Nanobody Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nanobody Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nanobody Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nanobody Drug Production Market Share 2022
Figure 30. China Based Manufacturers Nanobody Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nanobody Drug Production Market Share 2022
Figure 32. World Nanobody Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nanobody Drug Production Value Market Share by Type in 2022
Figure 34. Monovalent Nanobodies
Figure 35. Multivalent Nanobodies
Figure 36. Fusion Nanobodies
Figure 37. Others
Figure 38. World Nanobody Drug Production Market Share by Type (2018-2029)
Figure 39. World Nanobody Drug Production Value Market Share by Type (2018-2029)
Figure 40. World Nanobody Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Nanobody Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Nanobody Drug Production Value Market Share by Application in 2022
Figure 43. Tumor Treatment
Figure 44. Immune Disease Treatment
Figure 45. Inflammatory Disease Treatment
Figure 46. Others
Figure 47. World Nanobody Drug Production Market Share by Application (2018-2029)
Figure 48. World Nanobody Drug Production Value Market Share by Application (2018-2029)
Figure 49. World Nanobody Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Nanobody Drug Industry Chain
Figure 51. Nanobody Drug Procurement Model
Figure 52. Nanobody Drug Sales Model
Figure 53. Nanobody Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
